VBIO · Valion Bio, Inc. · Investor Relations
$1.14
-0.05 (-4.20%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's current cash levels and burn rate, amongst other things, the Company believes its cash and financial resources may be insufficient to meet the Company's anticipated needs for the twelve months following the date of issuance of the financial statements for the six months ended June 30, 2026, included elsewhere in this Report, which raises substantial doubt about the Company's ability to continue as a going concern within one year from the issuance date of the financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.05M
Shares
887,590
Volume · Oct 21
119.36K
Avg daily vol (36 sessions)
2.39M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-05-14 | Valion Bio to Report First Quarter 2026 Financial Results | Earnings call |
| 2026-04-01 | Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference | Conference |
| 2026-03-25 | Earnings conference call (announced in 8-K) | Earnings call |
Source: https://valionbio.com/investors/